Registered entities
ITEOS THERAPEUTICS, INC.
Reg. No. 84-3365066United States
Iteos Therapeutics, Inc.
Reg. No. 6677252United States
iTeos Belgium
Reg. No. 0838316659Belgium
Innovation
21 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,102 times.
| Year | Filings |
|---|---|
| 2015 | 7 |
| 2016 | 9 |
| 2017 | 12 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
Investor mix
21 investors on record; lead investors include RA Capital Management, Boxer Capital, SRIW, Vives Fund; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 48% |
| Private equity | 4 | 19% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 6 | 29% |